Back to results
US 6,492,507 B1Granted
Polynucleotides encoding human eosinophil-derived basic protein
AssigneeIncyte Genomics, Inc.
InventorIngrid E. Akerblom
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeIncyte Genomics, Inc.
InventorIngrid E. Akerblom
Estimating the term…
The present invention provides a human eosinophil-derived basic protein (EBPH) and polynucleotides which identify and encode EBPH. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding EBPH and a method for producing EBPH. The invention also provides for use of EBPH and agonists, antibodies or antagonists specifically binding EBPH, in the prevention and treatment of diseases associated with expression of EBPH. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding EBPH for the treatment of diseases associated with the expression of EBPH. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding EBPH.
An isolated and purified polynucleotide sequence encoding the eosinophil-derived basic protein of SEQ ID NO:1.
An isolated and purified polynucleotide sequence consisting of SEQ ID NO:2.
A polynucleotide sequence which is fully complementary to SEQ ID NO:2.
Dependencies are inferred from the claim text.